Bayberry Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 23-12-2024
- Paid Up Capital ₹ 0.10 M
as on 23-12-2024
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.64 Cr
as on 23-12-2024
- Revenue 9.34%
(FY 2022)
- Profit 5.23%
(FY 2022)
- Ebitda -4.23%
(FY 2022)
- Net Worth 5.71%
(FY 2022)
- Total Assets 5.75%
(FY 2022)
About Bayberry Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.64 Cr.
Gopal Zanuar and Sandeep Zanwar serve as directors at the Company.
- CIN/LLPIN
U24230PN2009PTC133910
- Company No.
133910
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 May 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bayberry Pharmaceuticals Private Limited offer?
Bayberry Pharmaceuticals Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Mineral Supplement, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Digestive System Drugs & Medicines, Antacid Drugs, Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Common Disease Medicines.
Who are the key members and board of directors at Bayberry Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopal Zanuar  | Director | 07-May-2009 | Current |
| Sandeep Zanwar | Director | 07-May-2009 | Current |
Financial Performance of Bayberry Pharmaceuticals.
Bayberry Pharmaceuticals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 9.34% increase. The company also saw a slight improvement in profitability, with a 5.23% increase in profit. The company's net worth moved up by a moderate rise of 5.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bayberry Pharmaceuticals?
Unlock access to Bayberry Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Sep 2020 | ₹8.90 M | Open |
Others Creation Date: 24 May 2017 | ₹7.50 M | Open |
How Many Employees Work at Bayberry Pharmaceuticals?
Unlock and access historical data on people associated with Bayberry Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bayberry Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bayberry Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
